DICE Therapeutics, Inc.
DICE Therapeutics, Inc. (DICE) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · DICE · as of Jun 30, 2023
Ownership Breakdown
182
Institutional Holders
▲ 64 vs Q1
$2.12B
Total Inst. Value
▲ $622.92M vs Q1
47.76M
Shares Outstanding
freeFloat 0.00%
45.61M
13F Shares Held
▼ 6.47M vs Q1
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
DICE largest shareholders · institutional ownership
Q2 2023 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
RA CAPITAL MANAGEMENT, L.P. pharmaceutical preparations | 7.86M | 16.65% | 16.65% | $365.02B | Aug 14, 2023 | — held |
BLACKROCK INC. pharmaceutical preparations | 2.90M | 6.13% | 6.13% | $134.52B | Aug 11, 2023 | ▼ 117.1K |
FMR LLC pharmaceutical preparations | 2.24M | 4.74% | 4.74% | $104.03B | Aug 11, 2023 | ▼ 3.44M |
AVORO CAPITAL ADVISORS LLC pharmaceutical preparations | 2.20M | 4.66% | 4.66% | $102.18B | Aug 14, 2023 | ▼ 1.75M |
ALPINE ASSOCIATES MANAGEMENT INC. pharmaceutical preparations | 2.12M | 4.49% | 4.49% | $98.35B | Aug 10, 2023 | NEW |
DRIEHAUS CAPITAL MANAGEMENT LLC pharmaceutical preparations | 2.04M | 4.32% | 4.32% | $94.70B | Aug 14, 2023 | ▲ 36.7K |
VANGUARD GROUP INC pharmaceutical preparations | 1.96M | 4.15% | 4.15% | $90.94B | Aug 14, 2023 | ▲ 29.2K |
MAGNETAR FINANCIAL LLC pharmaceutical preparations | 1.16M | 2.45% | 2.45% | $53.70B | Aug 11, 2023 | NEW |
PENTWATER CAPITAL MANAGEMENT LP pharmaceutical preparations | 1.08M | 2.29% | 2.29% | $50.20B | Aug 14, 2023 | NEW |
UBS OCONNOR LLC pharmaceutical preparations | 1.07M | 2.28% | 2.28% | $49.94B | Feb 14, 2024 | NEW |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q2 2023 vs prior quarter
Q2 2023
18
Increased
+4.76M shares21
New Positions
first time holders5
Decreased
−5.54M shares0
Sold Out
fully exitedNet shares change (top 50)
784.9K
+4.76M / −5.54M
Net new holders
+34
21 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
DICE insider trading · insider activity
Source: SEC Form 4
0
Buy transactions
38
Sell transactions
0.00
Buy/Sell ratio
$4M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
RA CAPITAL MANAGEMENT, L.P. | Aug 9, 2023 | D-Return | 21,250 | $14.98 | $318.3K | 0 | Form 4 ↗ |
RA CAPITAL MANAGEMENT, L.P. | Aug 9, 2023 | U-Tender | 786,407 | $0.00 | $78.641 | 0 | Form 4 ↗ |
TETLOW SHARON director | Aug 9, 2023 | D-Return | 21,250 | $14.98 | $318.3K | 0 | Form 4 ↗ |
TETLOW SHARON director | Aug 9, 2023 | D-Return | 49,841 | $0.00 | $4.984 | 0 | Form 4 ↗ |
TETLOW SHARON director | Aug 9, 2023 | D-Return | 13,800 | $17.00 | $234.6K | 0 | Form 4 ↗ |
Simson Jake director | Aug 9, 2023 | D-Return | 21,250 | $14.98 | $318.3K | 0 | Form 4 ↗ |
Scopa James Paul director | Aug 9, 2023 | D-Return | 13,800 | $17.00 | $234.6K | 0 | Form 4 ↗ |
Scopa James Paul director | Aug 9, 2023 | D-Return | 21,250 | $14.98 | $318.3K | 0 | Form 4 ↗ |
Scopa James Paul director | Aug 9, 2023 | D-Return | 25,722 | $0.00 | $2.572 | 0 | Form 4 ↗ |
Robertson Scott M. CFO & CBO | Aug 9, 2023 | D-Return | 56,920 | $17.00 | $967.6K | 0 | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
DICE Therapeutics, Inc. (DICE) is primarily owned by institutional investors, who hold approximately 95.5% of total shares outstanding. Company insiders own approximately 100.00%, while retail and public investors account for the remaining 0.00%.
The largest institutional shareholder of DICE Therapeutics, Inc. is RA CAPITAL MANAGEMENT, L.P., holding approximately 7.86 million shares — equal to 16.65% of outstanding shares — as of June 30, 2023.
A total of 182 institutional investors currently hold DICE stock, with a combined institutional value of approximately $2.12 billion as of the most recent 13F filing period.
Frequently asked questions
DICE ownershipDICE Therapeutics, Inc. (DICE) is primarily owned by institutional investors, who hold approximately 95.5% of shares. The largest shareholder is RA CAPITAL MANAGEMENT, L.P. with a 16.65% stake. Company insiders hold 100.00%. Data sourced from SEC Form 13F as of June 30, 2023.